-
Je něco špatně v tomto záznamu ?
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
P. Dubsky, K. Pinker, F. Cardoso, G. Montagna, M. Ritter, C. Denkert, IT. Rubio, E. de Azambuja, G. Curigliano, O. Gentilini, M. Gnant, A. Günthert, N. Hauser, J. Heil, M. Knauer, M. Knotek-Roggenbauerc, S. Knox, T. Kovacs, HM. Kuerer, S. Loibl,...
Jazyk angličtina Země Velká Británie
Typ dokumentu konsensus - konference, časopisecké články, směrnice pro lékařskou praxi, práce podpořená grantem, přehledy
NLK
ProQuest Central
od 2000-09-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2000-09-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2000-09-01 do Před 2 měsíci
Public Health Database (ProQuest)
od 2000-09-01 do Před 2 měsíci
- MeSH
- adjuvantní chemoterapie MeSH
- antitumorózní látky aplikace a dávkování škodlivé účinky MeSH
- delfská metoda MeSH
- klinické rozhodování MeSH
- konsensus MeSH
- lékařská onkologie normy MeSH
- lidé MeSH
- nádory prsu patologie terapie MeSH
- neoadjuvantní terapie škodlivé účinky normy MeSH
- segmentální mastektomie škodlivé účinky normy MeSH
- staging nádorů MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- konsensus - konference MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- směrnice pro lékařskou praxi MeSH
Primary systemic therapy is increasingly used in the treatment of patients with early-stage breast cancer, but few guidelines specifically address optimal locoregional therapies. Therefore, we established an international consortium to discuss clinical evidence and to provide expert advice on technical management of patients with early-stage breast cancer. The steering committee prepared six working packages to address all major clinical questions from diagnosis to surgery. During a consensus meeting that included members from European scientific oncology societies, clinical trial groups, and patient advocates, statements were discussed and voted on. A consensus was reached in 42% of statements, a majority in 38%, and no decision in 21%. Based on these findings, the panel developed clinical guidance recommendations and a toolbox to overcome many clinical and technical requirements associated with the diagnosis, response assessment, surgical planning, and surgery of patients with early-stage breast cancer. This guidance could convince clinicians and patients of the major clinical advancements purported by primary systemic therapy, the use of less extensive and more targeted surgery to improve the lives of patients with breast cancer.
Breast Center Eastern Switzerland St Gallen Switzerland
Breast Center University Hospital Basel Basel Switzerland
Breast Centre Aarau Cham Zug Hirslanden Klinik Aarau Switzerland
Breast Centre Hirslanden Klinik St Anna Luzern Switzerland
Breast Institute Jiahui International Hospital Shanghai China
Breast Service Department of Surgery Memorial Sloan Kettering Cancer Center New York NY USA
Breast Surgery San Raffaele University and Research Hospital Milan Italy
Breast Surgical Oncology Unit Clinica Universidad de Navarra Universidad de Navarra Madrid Spain
Breast Unit Champalimaud Clinical Center and Foundation Lisbon Portugal
Brust Zentrum Zurich Zurich Switzerland
Brustzentrum Bern Biel Bern Switzerland
Centre for Haematology and Oncology Bethanien Frankfurt Germany
Comprehensive Cancer Center Medical University of Vienna Vienna Austria
Department of Breast Surgery Guy's and St Thomas' NHS Foundation Trust London UK
Department of Breast Surgery Gyn zentrum Luzern Luzern Switzerland
Department of Surgery Antoni van Leeuwenhoek Netherlands Cancer Institute Amsterdam Netherlands
Department of Surgery Medical University of Vienna Vienna Austria
Europa Donna The European Breast Cancer Coalition Milan Italy
Faculty of Medicine and Health Sciences University of Antwerp Wilrijk Antwerp Belgium
Faculty of Medicine University of Basel Basel Switzerland
Frauenarztzentrum Aargau Ag Baden Switzerland
German Breast Group Neu Isenburg Germany
Heidelberg University Hospital Heidelberg Germany
Institut Jules Bordet Brussels Belgium
Institute of Pathology Philipps University Marburg and University Hospital Marburg Marburg Germany
Iridium Kankernetwerk Wilrijk Antwerp Belgium
Istituto Europeo di Oncologia IRCCS and University of Milano Milan Italy
l'Université Libre de Bruxelles Brussels Belgium
Nova Medical School Lisbon Portugal
Radiation Oncology Unit Oncology Department Azienda Ospedaliero Universitaria Careggi Florence Italy
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011671
- 003
- CZ-PrNML
- 005
- 20210507104825.0
- 007
- ta
- 008
- 210420s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S1470-2045(20)30580-5 $2 doi
- 035 __
- $a (PubMed)33387500
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Dubsky, Peter $u Breast Centre, Hirslanden Klinik St Anna, Luzern, Switzerland; Department of Surgery, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Electronic address: leitung-brustzentrum.stanna@hirslanden.ch
- 245 10
- $a Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox / $c P. Dubsky, K. Pinker, F. Cardoso, G. Montagna, M. Ritter, C. Denkert, IT. Rubio, E. de Azambuja, G. Curigliano, O. Gentilini, M. Gnant, A. Günthert, N. Hauser, J. Heil, M. Knauer, M. Knotek-Roggenbauerc, S. Knox, T. Kovacs, HM. Kuerer, S. Loibl, M. Mannhart, I. Meattini, F. Penault-Llorca, N. Radosevic-Robin, P. Sager, T. Španić, P. Steyerova, C. Tausch, MTFDV. Peeters, WP. Weber, MJ. Cardoso, P. Poortmans
- 520 9_
- $a Primary systemic therapy is increasingly used in the treatment of patients with early-stage breast cancer, but few guidelines specifically address optimal locoregional therapies. Therefore, we established an international consortium to discuss clinical evidence and to provide expert advice on technical management of patients with early-stage breast cancer. The steering committee prepared six working packages to address all major clinical questions from diagnosis to surgery. During a consensus meeting that included members from European scientific oncology societies, clinical trial groups, and patient advocates, statements were discussed and voted on. A consensus was reached in 42% of statements, a majority in 38%, and no decision in 21%. Based on these findings, the panel developed clinical guidance recommendations and a toolbox to overcome many clinical and technical requirements associated with the diagnosis, response assessment, surgical planning, and surgery of patients with early-stage breast cancer. This guidance could convince clinicians and patients of the major clinical advancements purported by primary systemic therapy, the use of less extensive and more targeted surgery to improve the lives of patients with breast cancer.
- 650 _2
- $a antitumorózní látky $x aplikace a dávkování $x škodlivé účinky $7 D000970
- 650 _2
- $a nádory prsu $x patologie $x terapie $7 D001943
- 650 _2
- $a adjuvantní chemoterapie $7 D017024
- 650 _2
- $a klinické rozhodování $7 D000066491
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a delfská metoda $7 D003697
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a segmentální mastektomie $x škodlivé účinky $x normy $7 D015412
- 650 _2
- $a lékařská onkologie $x normy $7 D008495
- 650 _2
- $a neoadjuvantní terapie $x škodlivé účinky $x normy $7 D020360
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a konsensus - konference $7 D016446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Pinker, Katja $u Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Vienna, Austria; Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 700 1_
- $a Cardoso, Fatima $u Breast Unit, Champalimaud Clinical Center and Foundation, Lisbon, Portugal
- 700 1_
- $a Montagna, Giacomo $u Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Breast Center, University Hospital Basel, Basel, Switzerland
- 700 1_
- $a Ritter, Mathilde $u Breast Center, University Hospital Basel, Basel, Switzerland
- 700 1_
- $a Denkert, Carsten $u Institute of Pathology, Philipps-University Marburg and University Hospital Marburg, Marburg, Germany
- 700 1_
- $a Rubio, Isabel T $u Breast Surgical Oncology Unit, Clinica Universidad de Navarra, Universidad de Navarra, Madrid, Spain
- 700 1_
- $a de Azambuja, Evandro $u Institut Jules Bordet, Brussels, Belgium; l'Université Libre de Bruxelles, Brussels, Belgium
- 700 1_
- $a Curigliano, Giuseppe $u Istituto Europeo di Oncologia, IRCCS and University of Milano, Milan, Italy
- 700 1_
- $a Gentilini, Oreste $u Breast Surgery, San Raffaele University and Research Hospital, Milan, Italy
- 700 1_
- $a Gnant, Michael $u Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Günthert, Andreas $u Breast Centre, Hirslanden Klinik St Anna, Luzern, Switzerland; Department of Breast Surgery, Gyn-zentrum Luzern, Luzern, Switzerland
- 700 1_
- $a Hauser, Nik $u Breast Centre Aarau Cham Zug, Hirslanden Klinik, Aarau, Switzerland; Frauenarztzentrum Aargau Ag, Baden, Switzerland
- 700 1_
- $a Heil, Joerg $u Heidelberg University Hospital, Heidelberg, Germany
- 700 1_
- $a Knauer, Michael $u Breast Center Eastern Switzerland, St Gallen, Switzerland
- 700 1_
- $a Knotek-Roggenbauerc, Mona $u Europa Donna-The European Breast Cancer Coalition, Milan, Italy
- 700 1_
- $a Knox, Susan $u Europa Donna-The European Breast Cancer Coalition, Milan, Italy
- 700 1_
- $a Kovacs, Tibor $u Department of Breast Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK; Breast Institute, Jiahui International Hospital, Shanghai, China
- 700 1_
- $a Kuerer, Henry M $u Division of Surgery, Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 700 1_
- $a Loibl, Sibylle $u German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany
- 700 1_
- $a Mannhart, Meinrad $u Breast Centre Aarau Cham Zug, Hirslanden Klinik, Aarau, Switzerland
- 700 1_
- $a Meattini, Icro $u Department of Experimental and Clinical Biomedical Sciences "M Serio", University of Florence, Florence, Italy; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
- 700 1_
- $a Penault-Llorca, Frederique $u Department of Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, University Clermont Auvergne, INSERM U1240 IMoST, Clermont-Ferrand, France
- 700 1_
- $a Radosevic-Robin, Nina $u Department of Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, University Clermont Auvergne, INSERM U1240 IMoST, Clermont-Ferrand, France
- 700 1_
- $a Sager, Patrizia $u Brustzentrum Bern Biel, Bern, Switzerland
- 700 1_
- $a Španić, Tanja $u Europa Donna-The European Breast Cancer Coalition, Milan, Italy
- 700 1_
- $a Steyerova, Petra $u Breast Cancer Screening and Diagnostic Center, Clinic of Radiology, General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Tausch, Christoph $u Brust-Zentrum Zurich, Zurich, Switzerland
- 700 1_
- $a Peeters, Marie-Jeanne T F D Vrancken $u Department of Surgery, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, Netherlands
- 700 1_
- $a Weber, Walter P $u Breast Center, University Hospital Basel, Basel, Switzerland; Faculty of Medicine, University of Basel, Basel, Switzerland
- 700 1_
- $a Cardoso, Maria J $u Breast Unit, Champalimaud Clinical Center and Foundation, Lisbon, Portugal; Nova Medical School, Lisbon, Portugal
- 700 1_
- $a Poortmans, Philip $u Iridium Kankernetwerk, Wilrijk-Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium
- 773 0_
- $w MED00011558 $t The Lancet. Oncology $x 1474-5488 $g Roč. 22, č. 1 (2021), s. e18-e28
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33387500 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507104823 $b ABA008
- 999 __
- $a ok $b bmc $g 1650135 $s 1132050
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 22 $c 1 $d e18-e28 $e - $i 1474-5488 $m Lancet oncology $n Lancet Oncol. $x MED00011558
- LZP __
- $a Pubmed-20210420
